Zobrazeno 1 - 10
of 64
pro vyhledávání: '"ACEI, Angiotensin converting enzyme inhibitor"'
Autor:
Runzhen Chen, Chen Liu, Peng Zhou, Jiannan Li, Jinying Zhou, Ying Wang, Xiaoxiao Zhao, Yi Chen, Shaodi Yan, Li Song, Hanjun Zhao, Hongbing Yan
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Despite the recommendations from mainstream guidelines, the use of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) for acute coronary syndrome (ACS) patients without heart failure (HF) is controvers
Externí odkaz:
https://doaj.org/article/e8e55f7f21eb4c609630a70deacf11d8
Autor:
Ian Tong, Shriram Nallamshetty, Kristin Dean, James W. Thompson, Collin Berg, Prentiss Taylor, Tony Yuan
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 6, Iss 1, Pp 19-26 (2022)
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Objectives To assess the effectiveness of telemedicine video visits in the management of hypertensive patients at home during the first year of the COVID-19 pandemic. We also evaluated associated measures of patient satisfaction with these holistic v
Publikováno v:
Progress in Biophysics and Molecular Biology
The coronavirus disease (COVID-19) arises from the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) which is an enveloped RNA virus. COVID-19 has rapidly spread throughout the world by infecting more than 143 million people and causing 3.
Publikováno v:
Indian Heart Journal, Vol 73, Iss 5, Pp 605-611 (2021)
Indian Heart Journal
Indian Heart Journal
Objectives We evaluated the efficacy and safety of dapagliflozin, a SGLT2i along with ARNI in refractory HFrEF irrespective of their diabetic status. Methods We performed a retrospective analysis of 104 symptomatic patients of HFrEF despite of optima
Publikováno v:
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica B, Vol 11, Iss 9, Pp 2749-2767 (2021)
Acta Pharmaceutica Sinica B, Vol 11, Iss 9, Pp 2749-2767 (2021)
Diabetic nephropathy (DN) has been recognized as a severe complication of diabetes mellitus and a dominant pathogeny of end-stage kidney disease, which causes serious health problems and great financial burden to human society worldwide. Conventional
Publikováno v:
International Journal of Pediatrics and Adolescent Medicine, Vol 8, Iss 2, Pp 121-124 (2021)
International Journal of Pediatrics & Adolescent Medicine
International Journal of Pediatrics & Adolescent Medicine
A 7-year-old boy was admitted to the Pediatric Cardiology Department with blood pressure of 160/120 mmHg accompanied by burning pain in his hands and feet and tachycardia, followed by a seizure attack for the first time in his life, which presented s
Publikováno v:
International Journal of Cardiology
Background Coronavirus disease 2019 (COVID-19) is a pandemic disease that is causing a public health emergency. Characteristics and clinical significance of myocardial injury remain unclear. Methods This retrospective single-center study analyzed 189
Autor:
Jalal Soleimani, Chanyan Huang, Amelia Barwise, Kelly Pennington, Yuliya Pinevich, Yue Dong, Svetlana Herasevich, Brian W. Pickering
Publikováno v:
Mayo Clinic Proceedings
A growing number of studies on coronavirus disease 2019 (COVID-19) are becoming available, but a synthesis of available data focusing on the critically ill population has not been conducted. We performed a scoping review to synthesize clinical charac
Autor:
Jane L. Shellum, Rajeev Chaudhry, Huzefa Bhopalwala, Thom W. Rooke, David A. Liedl, Vinod C. Kaggal, Robert D. McBane, Adelaide M. Arruda-Olson, Alisha P. Chaudhry, Ronald A. Hankey, Magali P. Disdier Moulder, Abby K. Hendricks, Ana I. Casanegra, Rick A. Nishimura, Iftikhar J. Kullo, Christopher G. Scott, Paul W. Wennberg
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 1, Pp 94-102 (2021)
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 1, Pp 94-102 (2021)
Objective To evaluate usability of a quality improvement tool that promotes guideline-based care for patients with peripheral arterial disease (PAD). Patients and Methods The study was conducted from July 19, 2018, to August 21, 2019. We compared the
Autor:
David Snipelisky, Antonio L. Perez, Adrian F. Hernandez, Marat Fudim, Natasha M. Lever, Omar F. AbouEzzeddine, Andrew N. Rosenbaum, David S. Raymer, Lynne W. Stevenson, Lauren Gilstrap, Matthew Nayor
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 4, Iss 5, Pp 529-536 (2020)
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Objective To describe the intent and early outcomes of elective inotrope use during heart failure hospitalization. Patients and Methods A prospective multisite design was used to collect data for hemodynamically stable patients started electively on